Abstract Details

Title Acute Leukemia in Multiple Sclerosis Patients Treated with Mitoxantrone in the Postmarketing Setting: The EMD Serono Experience

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 170

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ahmad M. Al-Sabbagh, MD (Avion Pharmaceuticals)	Dr. Al-Sabbagh has nothing to disclose.
	No disclosure on file
Randy Bennett (Serono Inc)	No disclosure on file
Fernando Dangond, MD, FAAN	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Alessandro S. Farias, PhD (University of Campinas)	No disclosure on file
	No disclosure on file

��ɫ��